NCT04573881
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Liver
Additional Notes: 
Exclusions: Patients with prior locoregional therapy (e.g. ablation, embolization, radiation) on the targeted tumor(s)
https://ClinicalTrials.gov/show/NCT04573881